John Mathew
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
John Mathew has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Debashish Danda
Department of Clinical Immunology and Rheumatology Christian Medical College Vellore India
8 shared publications - Ruchika Goel
Department of Clinical Immunology and Rheumatology, Christian Medical College and Hospital (CMCH), Vellore, India
6 shared publications P Sandhya
3 shared publicationsAshish K Badika
2 shared publicationsPp Anoof
2 shared publicationsR Subramanian
2 shared publications
Latest Publications
- Open Access
- 30 November 2011
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 6 (3) , S9-S10
P20 Clinical profile of anti-Ku autoantibody: a cohort study from a tertiary care centre in south India
- 30 November 2011
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 6 (3) , S9-S10
Open AccessP20 Clinical profile of anti-Ku autoantibody: a cohort study from a tertiary care centre in south India
- Open Access
- 30 November 2010
- Published by Medknow in Indian Journal of Rheumatology
- Vol. 5 (3) , S15
P7 Pancreatitis in systemic lupus erythematosus—case series over a period of three years from a tertiary care centre in South India
- 30 November 2010
- Published by Medknow in Indian Journal of Rheumatology
- Vol. 5 (3) , S15
Open AccessP7 Pancreatitis in systemic lupus erythematosus—case series over a period of three years from a tertiary care centre in South India
- Open Access
- 30 November 2010
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 5 (3) , S24
P46 TNF-α polymorphism in Takayasu's Arteritis—a preliminary study from tertiary centre in South India
- 30 November 2010
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 5 (3) , S24
Open AccessP46 TNF-α polymorphism in Takayasu's Arteritis—a preliminary study from tertiary centre in South India
- Open Access
- 30 November 2010
- Published by Medknow in Indian Journal of Rheumatology
- Vol. 5 (3) , S8
O21 Profile of serum pro-inflammatory versus anti-inflammatory cytokine and their correlation with disease activity in takayasu arteritis
- 30 November 2010
- Published by Medknow in Indian Journal of Rheumatology
- Vol. 5 (3) , S8
Open AccessO21 Profile of serum pro-inflammatory versus anti-inflammatory cytokine and their correlation with disease activity in takayasu arteritis
- Open Access
- 30 November 2010
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 5 (3) , S7
O18 Study of ultrasonography of hands in psoriatic arthritis in comparison with rheumatoid arthritis
- 30 November 2010
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 5 (3) , S7
Open AccessO18 Study of ultrasonography of hands in psoriatic arthritis in comparison with rheumatoid arthritis
- 1 October 2010
- Vol. 108 (10) , 677-8, 681
Parvovirus B19 serology in early inflammatory polyarthritis--experience from a tertiary core teaching hospital in South India.
This study was done to look for IgM antibody to parvovirus B19 in early inflammatory arthritis patients and their clinical correlations, if any. This was a retrospective case sheet based study and follow-up. IgM antibody to parvovirus B19 was studied in 47 patients who presented to the rheumatology outpatient department with early arthropathy of less than 24 weeks' duration during their first 3 months of onset or flare of arthritis. Seropositive patients were followed up till date. Seven out of the 47 patients had IgM parvo B19 antibody. Five of the 7 had underlying chronic infective, inflammatory and other pre-existing diseases. In 5 patients, the arthritis resolved completely. In the remaining 2, mild recurrent arthralgias were attributed to existing inflammatory diseases. Fever was present in the majority, but none of them had rash. The arthropathy was symmetrical type in the majority. Only 7 (14.8%) out the 47 patients with early inflammatory arthritis had antibody to parvovirus B19, 5 of the 7 had self-limiting course; there was no association of this virus with chronic inflammatory arthropathy in this cohort over a 9-year follow-up.
- 1 October 2010
- Vol. 108 (10) , 677-8, 681
Parvovirus B19 serology in early inflammatory polyarthritis--experience from a tertiary core teaching hospital in South India.
This study was done to look for IgM antibody to parvovirus B19 in early inflammatory arthritis patients and their clinical correlations, if any. This was a retrospective case sheet based study and follow-up. IgM antibody to parvovirus B19 was studied in 47 patients who presented to the rheumatology outpatient department with early arthropathy of less than 24 weeks' duration during their first 3 months of onset or flare of arthritis. Seropositive patients were followed up till date. Seven out of the 47 patients had IgM parvo B19 antibody. Five of the 7 had underlying chronic infective, inflammatory and other pre-existing diseases. In 5 patients, the arthritis resolved completely. In the remaining 2, mild recurrent arthralgias were attributed to existing inflammatory diseases. Fever was present in the majority, but none of them had rash. The arthropathy was symmetrical type in the majority. Only 7 (14.8%) out the 47 patients with early inflammatory arthritis had antibody to parvovirus B19, 5 of the 7 had self-limiting course; there was no association of this virus with chronic inflammatory arthropathy in this cohort over a 9-year follow-up.
- 7 January 2010
- Published by Springer Nature in Clinical Rheumatology
- Vol. 29 (3) , 329-332
Mycophenolate mofetil in Takayasu’s arteritis
Mycophenolate mofetil (MMf) has recently been reported as a useful alternative immunosuppressive drug in autoimmune diseases. There is paucity of literature on its use in Takayasu's arteritis (TA). The aim of this study was to assess the safety and efficacy of MMf in Asian Indian patients with Takayasu's arteritis. Records of 21 consecutive patients with TA on treatment with oral MMF attending our centre from January 2005 to August 2008 were studied. The clinical, laboratory and angiography findings were noted and disease activity assessment was done using Indian Takayasu's arteritis activity score (ITAS) and physician's global observation score at baseline and last follow-up. Eleven patients were on steroids alone at baseline while ten patients had received azathioprine prior to administration of mycophenolate. The mean duration of follow-up on mycophenolate was 9.6 (±6.4) months. Nineteen patients (90%) received mycophenolate due to active disease, while in the other two patients, it was given to facilitate steroid tapering. Mycophenolate had to be discontinued in one patient due to skin rash. At the last visit, all the remaining 20 patients who continued mycophenolate had improvement in disease activity as evident by the drop in median ITAS [7 (range 0–19) versus 1 (range 0–7); p = 0.001]. A similar trend was noted in laboratory markers of inflammation with a reduction in mean Erythrocyte Sedimentation Rate (ESR) (68 ± 36.5 versus 43.2 ± 34 mm/first hour; p = 0.003) and mean C - Reactive protein (CRP) (31 ± 46.7 versus 17.3 ± 23.9 mg/L; p = 1.00). All patients received concomitant steroids, but there was a significant decrease in steroid dosage from 36 (±16) mg/day at baseline to 19 (±14) mg/day at last follow-up (p < 0.001). This study is the largest series till date establishing the use of mycophenolate as a safe and effective steroid-sparing immunosuppressant in Takayasu's arteritis.
- 7 January 2010
- Published by Springer Nature in Clinical Rheumatology
- Vol. 29 (3) , 329-332
Mycophenolate mofetil in Takayasu’s arteritis
Mycophenolate mofetil (MMf) has recently been reported as a useful alternative immunosuppressive drug in autoimmune diseases. There is paucity of literature on its use in Takayasu's arteritis (TA). The aim of this study was to assess the safety and efficacy of MMf in Asian Indian patients with Takayasu's arteritis. Records of 21 consecutive patients with TA on treatment with oral MMF attending our centre from January 2005 to August 2008 were studied. The clinical, laboratory and angiography findings were noted and disease activity assessment was done using Indian Takayasu's arteritis activity score (ITAS) and physician's global observation score at baseline and last follow-up. Eleven patients were on steroids alone at baseline while ten patients had received azathioprine prior to administration of mycophenolate. The mean duration of follow-up on mycophenolate was 9.6 (±6.4) months. Nineteen patients (90%) received mycophenolate due to active disease, while in the other two patients, it was given to facilitate steroid tapering. Mycophenolate had to be discontinued in one patient due to skin rash. At the last visit, all the remaining 20 patients who continued mycophenolate had improvement in disease activity as evident by the drop in median ITAS [7 (range 0–19) versus 1 (range 0–7); p = 0.001]. A similar trend was noted in laboratory markers of inflammation with a reduction in mean Erythrocyte Sedimentation Rate (ESR) (68 ± 36.5 versus 43.2 ± 34 mm/first hour; p = 0.003) and mean C - Reactive protein (CRP) (31 ± 46.7 versus 17.3 ± 23.9 mg/L; p = 1.00). All patients received concomitant steroids, but there was a significant decrease in steroid dosage from 36 (±16) mg/day at baseline to 19 (±14) mg/day at last follow-up (p < 0.001). This study is the largest series till date establishing the use of mycophenolate as a safe and effective steroid-sparing immunosuppressant in Takayasu's arteritis.
- Open Access
- 30 November 2009
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 4 (3) , S8
P8 Perception of body image and sexuality of women with and without SLE in CMC, Vellore
- 30 November 2009
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 4 (3) , S8
Open AccessP8 Perception of body image and sexuality of women with and without SLE in CMC, Vellore
- Open Access
- 30 November 2009
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 4 (3) , S19
P59 A study of clinico-pathological correlation of non specific inflammation in bowel histology with joint manifestation
- 30 November 2009
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 4 (3) , S19
Open AccessP59 A study of clinico-pathological correlation of non specific inflammation in bowel histology with joint manifestation